Efficacy of subsequent therapies in patients (pts) with advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial according to whether disease progression occurred during or after the end of olaparib (ola) maintenance

被引：0

作者：

Harter, Philipp

Mouret-Reynier, Marie-Ange

Lorusso, Domenica

Cropet, Claire

Guerra, Eva M.

Wolfrum-Ristau, Pia

Matsumoto, Takashi

Vergote, Ignace

Colombo, Nicoletta

Maenpaa, Johanna Unelma

Lebreton, Coriolan

de Gregorio, Nikolaus

Mosconi, Anna Maria

Rubio-Perez, Maria Jesus

Bourgeois, Hugues

Fasching, Peter A.

Hardy-Bessard, Anne-Claire

Denschlag, Dominik

Pujade-Lauraine, Eric

Ray-Coquard, Isabelle Laure

机构：

[1] Kliniken Essen Mitte, Essen, Germany

[2] AGO, Essen, Germany

[3] Ctr Jean Perrin, Clermont Ferrand, France

[4] GINECO, Clermont Ferrand, France

[5] Fdn Policlin Univ A Gemelli IRCCS, Ist Tumori Milano, Rome, Italy

[6] Univ Cattolica Sacro Cuore, Rome, Italy

[7] MITO, Rome, Italy

[8] Ctr Leon Berard, Lyon, France

[9] GINECO, Lyon, France

[10] Hosp Univ Ramon & Cajal, Madrid, Spain

[11] GEICO, Madrid, Spain

[12] Paracelsus Med Univ Salzburg, Salzburg, Austria

[13] AGO Au, Salzburg, Austria

[14] Ehime Univ Hosp, Toon, Japan

[15] GOTIC, Toon, Japan

[16] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium

[17] BGOG, Leuven, Belgium

[18] Univ Milano Bicocca, Milan, Italy

[19] European Inst Oncol IRCCS, Milan, Italy

[20] MANGO, Milan, Italy

[21] Tampere Univ Hosp, Tampere, Finland

[22] NSGO, Tampere, Finland

[23] Inst Bergonie, Bordeaux, France

[24] GINECO, Bordeaux, France

[25] Univ Klinikum Ulm, Klin Frauenheilkunde & Geburtshilfe, Ulm, Germany

[26] AGO, Ulm, Germany

[27] SC Oncol Med Osp S Maria della Misericordia AO Pe, Perugia, Italy

[28] MITO, Perugia, Italy

[29] Hosp Reina Sofia, Cordoba, Spain

[30] GEICO, Cordoba, Spain

[31] Ctr Jean Bernard Clin Victor Hugo, Le Mans, France

[32] GINECO, Le Mans, France

[33] Univ Frauenklin Erlangen, Erlangen, Germany

[34] AGO, Erlangen, Germany

[35] Ctr CARIO HPCA, Plerin Sur Mer, France

[36] GINECO, Plerin Sur Mer, France

[37] Hochtaunuskliniken, Bad Homburg, Germany

[38] AGO, Bad Homburg, Germany

[39] ARCAGY Res, Paris, France

[40] GINECO, Paris, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5550

引用

页数：1

共 39 条

[1] Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
Harter, Philipp
Mouret-Reynier, Marie Ange
Pignata, Sandro
Cropet, Claire
Gonzalez-Martin, Antonio
Bogner, Gerhard
Fujiwara, Keiichi
Vergote, Ignace
Colombo, Nicoletta
Nottrup, Trine Jakobi
Floquet, Anne
El-Balat, Ahmed
Scambia, Giovanni
Guerra Alia, Eva Maria
Fabbro, Michel
Schmalfeldt, Barbara
Hardy-Bessard, Anne-Claire
Runnebaum, Ingo
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
GYNECOLOGIC ONCOLOGY, 2022, 164 (02) : 254 - 264
[2] EFFICACY OF SUBSEQUENT CHEMOTHERAPY FOLLOWED BY PARP INHIBITOR MAINTENANCE IN PATIENTS WITH ADVANCED OVARIAN CANCER IN THE PHASE III PAOLA-1/ENGOT-OV25 TRIAL
Marth, Christian
Mouret-Reynier, Marie-Ange
Lorusso, Domenica
Cropet, Claire
Harter, Philipp
Guerra, Eva
Matsumoto, Takashi
Vergote, Ignace
Colombo, Nicoletta
Maenpaa, Johanna
Lebreton, Coriolan
De Gregorio, Nikolaus
Mosconi, Anna Maria
Rubio, Maria Jesus
Bourgeois, Hugues
Fasching, Peter A.
Hardy-Bessard, Anne-Claire
Denschlag, Dominik
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A21 - A21
[3] Final overall survival (OS) results from the phase III PAOLA-1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)
Ray-Coquard, I. L.
Leary, A.
Pignata, S.
Cropet, C.
Gonzalez Martin, A. J.
Bogner, G.
Yoshida, H.
Vergote, I. B.
Colombo, N.
Maenpaa, J.
Selle, F.
Schmalfeldt, B.
Scambia, G.
Guerra Alia, E. M.
Lefeuvre-Plesse, C.
Belau, A.
Lortholary, A.
Gropp-Meier, M.
Pujade-Lauraine, E.
Harter, P.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1396 - S1397
[4] Efficacy of maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced ovarian cancer according to BRCA mutation genotype in the phase III PAOLA-1/ENGOT-ov25 trial.
Labidi-Galy, Sana Intidhar
Rodrigues, Manuel
Sandoval, Jose L.
Kurtz, Jean Emmanuel
Heitz, Florian
Mosconi, Anna Maria
Romero, Ignacio
Berger, Regina
Nagao, Shoji
Vergote, Ignace
Parma, Gabriella
Nottrup, Trine Jakobi
Rouleau, Etienne
Garnier, Georges
El-Balat, Ahmed
Zamagni, Claudio
Martin-Lorente, Cristina
Pujade-Lauraine, Eric
Fievet, Alice
Ray-Coquard, Isabelle Laure
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[5] Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial
Sabatier, Renaud
Rousseau, Frederique
Joly, Florence
Cropet, Claire
Montegut, Coline
Frindte, Johanna
Cinieri, Saverio
Alia, Eva M. Guerra
Polterauer, Stephan
Yoshida, Hiroyuki
Vergote, Ignace
Colombo, Nicoletta
Hietanen, Sakari
Largillier, Remi
Canzler, Ulrich
Gratet, Alain
Marme, Frederik
Favier, Laure
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
EUROPEAN JOURNAL OF CANCER, 2023, 181 : 42 - 52
[6] Final overall survival (OS) results from the phase III PAOLA1/ENGOT-ov25 trial evaluating maintenance olaparib (ola) plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC)
Nagao, S.
Harter, P.
Leary, A.
Cropet, C.
Pignata, S.
Fujiwara, K.
Gonzalez Martin, A. J.
Bogner, G.
Vergote, I.
Colombo, N.
Maenpaa, J.
Selle, F.
Schmalfeldt, B.
Scambia, G.
Guerra Alia, E. M.
Lefeuvre-Plesse, C.
Belau, A.
Lortholary, A.
Gropp-Meier, M.
Pujade-Lauraine, E.
Ray-Coquard, I.
ANNALS OF ONCOLOGY, 2022, 33 : S1503 - S1504
[7] Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
Fujiwara, Keiichi
Fujiwara, Hiroyuki
Yoshida, Hiroyuki
Satoh, Toyomi
Yonemori, Kan
Nagao, Shoji
Matsumoto, Takashi
Kobayashi, Hiroaki
Bourgeois, Hughes
Harter, Philipp
Mosconi, Anna Maria
Palacio Vazquez, Isabel
Reinthaller, Alexander
Fujita, Tomoko
Rowe, Philip
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (05)
[8] Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
Lorusso, Domenica
Mouret-Reynier, Marie-Ange
Harter, Philipp
Cropet, Claire
Caballero, Cristina
Wolfrum-Ristau, Pia
Satoh, Toyomi
Vergote, Ignace
Parma, Gabriella
Nottrup, Trine J.
Lebreton, Coriolan
Fasching, Peter A.
Pisano, Carmela
Manso, Luis
Bourgeois, Hugues
Runnebaum, Ingo
Zamagni, Claudio
Hardy-Bessard, Anne-Claire
Schnelzer, Andreas
Fabbro, Michel
Schmalfeldt, Barbara
Berton, Dominique
Belau, Antje
Lotz, Jean-Pierre
Gropp-Meier, Martina
Gladieff, Laurence
Lueck, Hans-Joachim
Abadie-Lacourtoisie, Sophie
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 550 - 558
[9] Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
Gonzalez-Martin, Antonio
Desauw, Christophe
Heitz, Florian
Cropet, Claire
Gargiulo, Piera
Berger, Regina
Ochi, Hiroyuki
Vergote, Ignace
Colombo, Nicoletta
Mirza, Mansoor R.
Tazi, Youssef
Canzler, Ulrich
Zamagni, Claudio
Guerra-Alia, Eva M.
Levache, Charles B.
Marme, Frederik
Bazan, Fernando
de Gregorio, Nikolaus
Dohollou, Nadine
Fasching, Peter A.
Scambia, Giovanni
Rubio-Perez, Maria J.
Milenkova, Tsveta
Costan, Cristina
Pautier, Patricia
Ray-Coquard, Isabelle
EUROPEAN JOURNAL OF CANCER, 2022, 174 : 221 - 231
[10] PHASE III PAOLA-1/ENGOT-OV25 TRIAL: OLAPARIB PLUS BEVACIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, ADVANCED OVARIAN CANCER TREATED WITH PLATINUM-BASED CHEMOTHERAPY PLUS BEVACIZUMAB
Harter, P.
Mouret-Reynier, M. A.
Pignata, S.
Cropet, C.
Gonzalez-Martin, A.
Bogner, G.
Fujiwara, K.
Vergote, I.
Colombo, N.
Maenpaa, J.
Floquet, A.
El-Balat, A.
Lorusso, D.
Guerra Alia, E. M.
Fabbro, M.
Schmalfeldt, B.
Blessard, A. C. Hardy
Runnebaum, I.
Pujade-Lauraine, E.
Ray-Coquard, I.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A10 - A11

← 1 2 3 4 →